What is your role at your work?

I am a clinical doctor (chief physician and a professor in Cardiology). In the last 10 years I have been
interested in female hypertension.

How did you get interested in your career path?

I took part in national and international conferences. Through these events I met many wise professors
and learnt much from them.

What are you most proud of in your career or otherwise?

I was recommended to join the 2021 WHO Hypertension Guidelines Committee as a Guideline
Development Group member.

What important career challenges have you faced and how did you overcome them?

In mainland China, it is very challenging for female doctors to balance clinical work, teaching, and family
care.

What advice would you give your younger self?

Don't give up. Keep learning.

Highlight your most significant research contributions and publications (3-5) - if relevant to
you.

I started my research about female sexual dysfunction of hypertension in 2010. As a corresponding
author I conducted a study and published several papers. Later on, I focused on the tumor and
antitumor drugs associated with hypertension, hypertension related diseases especially female
hypertension.

1. Liu, Q., Si, F., Wu, Y., & Yu, J. Association between transitions in metabolic health and colorectal
cancer across categories of body size phenotype: a prospective cohort study. Obesity (Silver
Spring, Md.). 2024,32(10): 1948–1957.

2. Liu Q, Si F, Liu Z, Wu Y, Yu J. Association between triglyceride-glucose index and risk of
cardiovascular disease among postmenopausal women. Cardiovasc Diabetol. 2023;22(1):21.
Published 2023 Jan 30. doi:10.1186/s12933-023-01753-3.

3. Chen J, Pei Y, Wang Q, Li C, Liang W, Yu J. Effect of sacubitril/valsartan or valsartan on
ventricular remodeling and myocardial fibrosis in perimenopausal women with hypertension. J
Hypertens. 2023;41(7):1077-1083.

4. Zhao Y., Wang Q., Zhao X., Meng H., & *Yu J. Effect of antihypertensive drugs on breast cancer
risk in female hypertensive patients: evidence from observational studies. Clinical and Experimental
Hypertension, 10.1080/ 10641963.2017. 1288736。
5. Ruixin Ma, *Jing Yu, Dian Xu, et al. Effect of felodipine with irbesartan or metoprolol on sexual
function and oxidative stress in women with essential hypertension[J].J of Hypertension.2012,30(1)
210-216.

Have you had any significant career mentors? If yes, please provide further details.

I was an active member of the China Hypertension League more then 20 years ago and they held a
training project called CHIEF forum. Chinese predecessors including Prof. Zhaosu Wu, Prof. Ningling
Sun, and Weizhong Zhang guided us a lot at this event. I admire them very much and will never forget
these people.

How can we support the next generation of women scientists?

We really need to actively support young female clinicians, community physicians, and researchers in
the field of hypertension. We should discover them and encourage them like the Chinese old story
BOLE. When we recruit students, we also need to consciously encourage female students. We should
actively give opportunities to promising female young scholars. We can also conduct training projects
for young female scholars such as summer classes.